For investors

Revolutionizing healthcare with proactive approach

The problem

Today’s healthcare waits for problems. We’re changing that — enabling early risk detection and proactive care that saves lives, reduces costs, and drives a trillion-dollar industry.

50

%

CARDIOVASCULAR

Half of acute heart events are preventable with early detection.

4

X

CANCER DETECTION

Early detection increases survival rates from 20% to 90%.

60

%

AUTOIMMUNE

Treatment in the first 12 weeks leads to remission in 60%+ of patients.

37

%

DIABETES

Early detection reduces the risk of severe complications by 37%.

9

X

INFECTIOUS DISEASES

Mortality rates can be up to 9× lower with early-stage diagnosis.

The solution

This is Hea detects issues that often go unnoticed by the body — using smart questions, deep personalization, and voice check-ins.

We track user data, monitor progress, and guide daily actions that truly matter — from simple habits to follow-up tests. With our subscription model, proactive care becomes the norm, powered by continuous monitoring and AI-driven insights.

This is Hea detects issues that often go unnoticed by the body — using smart questions, deep personalization, and voice check-ins.some text inside of a div block.

We track user data, monitor progress, and guide daily actions that truly matter — from simple habits to follow-up tests. With our subscription model, proactive care becomes the norm, powered by continuous monitoring and AI-driven insights.

The progress

Clinical model trained on public & anonymised data sets

MVP design finished, early testing with users aged 30–45

First UK-focused launch mid-2025

Partnerships in negotiation (labs / B2B wellness pilots)

Meet founders

Alex Remez

Co-Founder HEA, Founder & Former CEO of UNIM – one of the biggest Digital Pathology company in the world.

Igor Ryabenkiy

Co-Founder HEA & Managing Partner at AltaIR Capital

Health is shifting — and we know how to lead the change

With our extensive experience successfully scaling HealthTech startups, we’re ready to reshape the future of preventive care. Let’s discuss how we can partner to accelerate product development, strategic partnerships, and regulatory compliance, bringing Hea to early adopters in the UK and beyond.

$37.6B

Projected UK digital health market size by the early 2030s — growing from $12.8B today at an average annual rate (CAGR) of 12%.

$327.7B in 2024

the size of the global health screening market, projected to grow to $840.8B by 2032 (CAGR ~12.5%) driven by demand for earlier detection and proactive care.

$585.6B

the expected value of the preventive healthcare market by 2030, valued at $268.7B in 2023.

20-40%

Fewer hospitalizations with remote health monitoring — and approximately $2,700 saved per patient annually.

We’re inviting visionary investors & venture capitalists to join us in transforming healthcare from a reactive to a proactive model

Request our full pitch deck — we’ll share the numbers.

Request pitch-deck